196 related articles for article (PubMed ID: 10069247)
1. Epidemiologic evidence for a new class of compounds associated with toxic oil syndrome.
Posada de la Paz M; Philen RM; Schurz H; Hill RH; Giménez Ribota O; Gómez de la Camara A; Kilbourne EM; Abaitua I
Epidemiology; 1999 Mar; 10(2):130-4. PubMed ID: 10069247
[TBL] [Abstract][Full Text] [Related]
2. Chemical correlates of pathogenicity of oils related to the toxic oil syndrome epidemic in Spain.
Kilbourne EM; Bernert JT; Posada de la Paz M; Hill RH; Abaitua Borda I; Kilbourne BW; Zack MM
Am J Epidemiol; 1988 Jun; 127(6):1210-27. PubMed ID: 3369420
[TBL] [Abstract][Full Text] [Related]
3. Possible etiologic agents for toxic oil syndrome: fatty acid esters of 3-(N-phenylamino)-1,2-propanediol.
Hill RH; Schurz HH; Posada de la Paz M; Abaitua Borda I; Philen RM; Kilbourne EM; Head SL; Bailey SL; Driskell WJ; Barr JR
Arch Environ Contam Toxicol; 1995 Feb; 28(2):259-64. PubMed ID: 7710294
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with pathogenicity of oils related to the toxic oil syndrome epidemic in Spain.
Posada de la Paz M; Philen RM; Abaitua Borda I; Diez Ruiz-Navarro M; Abraira Santos V; Pozo Rodríguez F; Pla Mestre R; Pollán Santamaría M; Sicilia Socias JM; Azpeitia Gamazo P
Epidemiology; 1994 Jul; 5(4):404-9. PubMed ID: 7918809
[TBL] [Abstract][Full Text] [Related]
5. Toxic oil syndrome: traceback of the toxic oil and evidence for a point source epidemic.
Posada de la Paz M; Philen RM; Borda IA; Sicilia Socias JM; Gómez de la Cámara A; Kilbourne EM
Food Chem Toxicol; 1996 Mar; 34(3):251-7. PubMed ID: 8621106
[TBL] [Abstract][Full Text] [Related]
6. On the generation and outcome of 3-(N-phenylamino)propane-1,2-diol derivatives in deodorized model oils related to toxic oil syndrome.
Morató A; Escabrós J; Manich A; Reig N; Castaño Y; Abián J; Messeguer A
Chem Res Toxicol; 2005 Apr; 18(4):665-74. PubMed ID: 15833026
[TBL] [Abstract][Full Text] [Related]
7. Storage time and deodorization temperature influence the formation of aniline-derived compounds in denatured rapeseed oils.
Ruiz-Méndez MV; Posada de la Paz M; Abian J; Calaf RE; Blount B; Castro-Molero N; Philen R; Gelpí E
Food Chem Toxicol; 2001 Jan; 39(1):91-6. PubMed ID: 11259855
[TBL] [Abstract][Full Text] [Related]
8. Products of aniline and triglycerides in oil samples associated with the toxic oil syndrome.
Schurz HH; Hill RH; Posada de la Paz M; Philen RM; Borda IA; Bailey SL; Needham LL
Chem Res Toxicol; 1996 Sep; 9(6):1001-6. PubMed ID: 8870988
[TBL] [Abstract][Full Text] [Related]
9. Potential implication of aniline derivatives in the Toxic Oil Syndrome (TOS).
Messeguer A
Chem Biol Interact; 2011 Jun; 192(1-2):136-41. PubMed ID: 20970410
[TBL] [Abstract][Full Text] [Related]
10. Study of apoptosis in human lymphocytes by toxic substances implicated in toxic oil syndrome.
Gallardo S; Cárdaba B; del Pozo V; de Andrés B; Cortegano I; Jurado A; Tramón P; Palomino P; Lahoz C
Toxicology; 1997 Mar; 118(1):71-82. PubMed ID: 9074655
[TBL] [Abstract][Full Text] [Related]
11. Toxic oil syndrome: the perspective after 20 years.
Posada de la Paz M; Philen RM; Borda AI
Epidemiol Rev; 2001; 23(2):231-47. PubMed ID: 12192735
[TBL] [Abstract][Full Text] [Related]
12. Biotransformation of 3-(phenylamino)-1,2-propanediol to 3-(phenylamino)alanine: a chemical link between toxic oil syndrome and eosinophilia-myalgia syndrome.
Mayeno AN; Benson LM; Naylor S; Colberg-Beers M; Puchalski JT; Gleich GJ
Chem Res Toxicol; 1995; 8(7):911-6. PubMed ID: 8555405
[TBL] [Abstract][Full Text] [Related]
13. Studies on toxic oil syndrome: stereoselective hydrolysis of 3-(phenylamino)propane-1,2-diol esters by human pancreatic lipase.
Morató A; Martínez-Cabot A; Escabrós J; Bujons J; Messeguer A
Chem Res Toxicol; 2004 Jul; 17(7):889-95. PubMed ID: 15257613
[TBL] [Abstract][Full Text] [Related]
14. LC-MS ion maps for the characterization of aniline derivatives of fatty acids and triglycerides in laboratory-denatured rapeseed oil.
Reig N; Calaf RE; Messeguer A; Morató A; Escabros J; Gelpí E; Abian J
J Mass Spectrom; 2007 Apr; 42(4):527-41. PubMed ID: 17295417
[TBL] [Abstract][Full Text] [Related]
15. Toxic oil syndrome: a current clinical and epidemiologic summary, including comparisons with the eosinophilia-myalgia syndrome.
Kilbourne EM; Posada de la Paz M; Abaitua Borda I; Diez Ruiz-Navarro M; Philen RM; Falk H
J Am Coll Cardiol; 1991 Sep; 18(3):711-7. PubMed ID: 1869734
[TBL] [Abstract][Full Text] [Related]
16. Biotransformation and clearance of 3-(phenylamino)propane-1,2-diol, a compound present in samples related to toxic oil syndrome, in C57BL/6 and A/J mice.
Ladona MG; Bujons J; Messeguer A; Ampurdanés C; Morató A; Corbella J
Chem Res Toxicol; 1999 Dec; 12(12):1127-37. PubMed ID: 10604860
[TBL] [Abstract][Full Text] [Related]
17. The toxic oil syndrome: a perspective on immunotoxicological mechanisms.
Yoshida SH; German JB; Fletcher MP; Gershwin ME
Regul Toxicol Pharmacol; 1994 Feb; 19(1):60-79. PubMed ID: 8159816
[TBL] [Abstract][Full Text] [Related]
18. The association of oil ingestion with toxic oil syndrome in two convents.
Diaz de Rojas F; Castro García M; Abaitua Borda I; Alonso Gordo JM; Posada de la Paz M; Kilbourne EM; Tabuenca Oliver JM
Am J Epidemiol; 1987 May; 125(5):907-11. PubMed ID: 3565366
[TBL] [Abstract][Full Text] [Related]
19. Detection and isolation of pentachlorophenol in oil samples associated with the Spanish toxic oil syndrome.
Guitart R; Abián J; Arboix M; Gelpí E
Bull Environ Contam Toxicol; 1990 Aug; 45(2):181-8. PubMed ID: 2400832
[No Abstract] [Full Text] [Related]
20. Immunological basis of toxic oil syndrome (TOS).
Gallardo S; del Pozo V; Cárdaba B; de Andrés B; Martín-Orozco E; Fernandez JC; Tramón P; Posada M; Abaitua I; Palomino P
Toxicology; 1994 Nov; 93(2-3):289-99. PubMed ID: 7974520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
